Avicenna Day 2020
Tuesday 25 August 2020
Time: 14.00 – 18:30 CEST / 13.00 - 17.30 BST / 17.30 - 22.00 IST / 8.00 - 12.30 EDT / 7.00 -11.30 CDT
14:00 – 14:15 |
Welcome and presentation of the Avicenna Successful JourneyThierry Marchal, Secretary General, Avicenna Alliance |
14:15 – 14:40 |
Successful use of in silico for regulatory approval |
|
14:15 – 14:25 |
Medical Device Case study – Steven Levine, Dassault Systèmes |
|
14:25 – 14:35 |
Pharmaceutical case study – François Boissel, Novadiscovery |
|
14:35 – 14:40 |
Q&A with the audience moderated by Alicia Waterkeyn (Avicenna Secretariat, RPP group) |
14:40 – 15:55 |
Session I - A policy community |
|
14:40 – 14:55 |
Mission, achievements and planEmmanuelle Voisin, Policy Development Working Group Leader, Voisin Consulting Life Sciences |
|
14:55 – 15:05 |
Important directions for Europe in 2021 & 2022James Kennedy, Avicenna Secretariat, RPP Group |
|
15:05 – 15:15 |
Towards Good Simulation PracticeLuca Emili, Chair of the GSP Taskforce, InsilicoTrials Technologies |
|
15:15 – 15:30 |
A valuable collaboration with EMALiesbet Geris Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven Flora Musuamba, European Medicines Agency, Modelling and Simulation Working Party |
|
15:30 – 15:45 |
Engaging with Notified BodiesSimon Sonntag, Chair of the Notified Bodies Taskforce, Virtonomy Françoise Schlemmer, Director, The European Association for Medical devices of Notified Bodies (Team-NB)) |
|
15:45 – 15:55 |
Q&A with the audience moderated by Alicia Waterkeyn, RPP group |
15:55 – 16:25 |
Session II - An international community |
|
15:55 – 16:00 |
Mission, achievements and planMarkus Reiterer, International Working Group Leader, Medtronic |
|
16:00 – 16:10 |
Computer modelling as regulatory evidence at FDABrent Craven, U.S. Food and Drug Administration |
|
16:10 – 16:20 |
Global Recommendations for in silico EvidenceMarc Horner, Ansys |
|
16:20 – 16:25 |
Q&A with the audience moderated by Alicia Waterkeyn, RPP group |
16:25 – 16:40 |
Break |
16:40 – 17:45 |
Session III - A research & technology community |
|
16:40 – 16:50 |
Mission, achievements and planLiesbet Geris, Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven |
|
16:50 – 17:05 |
Certified Materials LibraryVenkat Perumal, Chair of the Materials Library Taskforce, Stryker Nele Famaey, KU Leuven |
|
17:05 – 17:20 |
Funding for in silico in Horizon Europe projectsLiesbet Geris, VPHi, KU Leuven, ULiege Nathalie Virag, Medtronic |
|
17:20 – 17:35 |
The role of AI for in silico medicineJérôme Noailly, VPHi, Pompeu Fabra University, Barcelona Payman Afshari, DePuy Spine, Johnson and Johnson |
|
17:35 – 17:45 |
Q&A with the audience moderated by Alicia Waterkeyn, RPP group |
17:45 – 18:20 |
Session IV – Interactive Panel Discussion with Avicenna Alliance Board MembersLiesbet Geris, Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven Emmanuelle Voisin, Policy Development Working Group Leader, Voisin Consulting Life Science Markus Reiterer, International Working Group Leader, Medtronic Luca Emili, Avicenna Treasurer, InsilicoTrials Technologies James Kennedy, Avicenna Secretariat, RPP Group Thierry Marchal, Secretary General, Avicenna Alliance |
18:20 – 18:30 |
Concluding RemarksThierry Marchal, Secretary General, Avicenna Alliance |
